BridgeMD
New treatment option for HIV Infections
Official title Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
ClinicalTrials.gov ID: NCT05602376
What this study is testing
- What it's testing
- This study will evaluate the impact of U=U messaging and counseling on gaps in the HIV care cascade for men, including testing uptake and ART initiation (Aim 1), achieving viral suppression and retention in care (Aim 2) in two provinces in South Africa. The U=U message communicates the compelling idea that PLHIV who take ART and have an undetectable viral load (\<200 copies/mL) cannot sexually transmit HIV.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 and older, men only. Healthy volunteers may be eligible.
You may be able to join if
- AIM 1:
- male
- aged ≥15 years
- present a study issued invitation card to site receptionist
- ability to provide informed consent. AIM 2:
See the full eligibility criteria
- AIM 1:
- male
- aged ≥15 years
- present a study issued invitation card to site receptionist
- ability to provide informed consent. AIM 2:
- cis-gender men
- aged ≥15 years
- newly initiating ART (i.e., treatment naïve) or re-initiating ART after 6 months of being lost-to-care
- live in Buffalo City or Cape Town Metro Health Districts
- provide written informed consent
The study team makes the final eligibility decision.
Where it's taking place
- East London, Eastern Cape, South Africa
- Cape Town, Western Cape, South Africa
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 15 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include East London, Eastern Cape, South Africa; Cape Town, Western Cape, South Africa. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.